Shanghai Pharmaceutical Enterprise Layout Shandong Pharmaceutical Logistics
Release time: 2010-05-21 & nbsp & nbsp & nbsp Source:
On the morning of the 19th，Shandong Pharmaceutical Business Lianlian Pharmaceutical Co., Ltd., which was jointly established by Shanghai Medical Division Holdings stake online sports bettingstake online sports bettingCo., Ltd. and Shandong Commercial Lianlian Biochemical Pharmaceutical Co., Ltd.。The new company will form a logistics distribution center and sales center that radiates the province with Jinan as the center，Created as a modern pharmaceutical logistics enterprise。This is also the first national expansion project after the reorganization of the Pharmaceutical Group in March this year。
"The whole plan has been brewing for more than half a year，Now it is finally implemented。"New Shandong Pharmaceutical Business Lianye Pharmaceutical Co., Ltd. Zhang Rong told reporters，Shandong is one of the largest pharmaceutical markets in China，The drug distribution before the establishment of the new company must pass through multiple intermediate links，Not only increased the delivery cost, but the existence of multiple circulation links also pushed the drug price，The next step of medical reform is also emphasizing reducing drug circulation.，New medicine is also My stake betting appMy stake betting appconforming to the trend of medical reform。"The key to the new company can improve the efficiency of drug distribution，Especially for the first aid for some diseased number demand and the hospital's medicine library is short。”
New Shanghai Pharmaceutical Group is marked with the resumption of listing on the Shanghai Stock Exchange on March 9 this year，Completed with Shanghai Industrial Group、Reorganization of the core pharmaceutical assets under the Shanghai Pharmaceutical Group。New medicine is committed to becoming the entire industry chain covering the pharmaceutical industry、The most competitive comprehensive pharmaceutical industry group and the main integrated person in the Chinese pharmaceutical industry，Layout the Shandong market is the first step that it takes。"We will integrate other resources in Shandong in 3 years，Enter the forefront of the Shandong Pharmaceutical Distribution Market。"Ge Jianqiu, Vice President of Shanghai Pharmaceutical stake betting appstake online sports bettingGroup Co., Ltd. said，Next new medicine will also copy and promote this cooperation mode in Shandong，Accelerate the pace of expansion nationwide。
It is understood，Shanghai Pharmaceutical Distribution Holdings Co., Ltd.，It is also China's largest current scale、One of the most widely network medical business enterprises，Founded in 1997 Shandong Commercial Lianhua Biochemical Pharmaceutical Co., Ltd.，has gradually formed Jinan as the center、The pharmaceutical marketing network covering Shandong，cooperation between the two can be described as complementary advantages。According to disclosure，New Company Shanghai Fang Fang accounts for 60%of the shares，Shandong Shanglian Biochemical accounts for 40%of the shares。
"The whole plan has been brewing for more than half a year，Now it is finally implemented。"New Shandong Pharmaceutical Business Lianye Pharmaceutical Co., Ltd. Zhang Rong told reporters，Shandong is one of the largest pharmaceutical markets in China，The drug distribution before the establishment of the new company must pass through multiple intermediate links，Not only increased the delivery cost, but the existence of multiple circulation links also pushed the drug price，The next step of medical reform is also emphasizing reducing drug circulation.，New medicine is also My stake betting appMy stake betting appconforming to the trend of medical reform。"The key to the new company can improve the efficiency of drug distribution，Especially for the first aid for some diseased number demand and the hospital's medicine library is short。”
New Shanghai Pharmaceutical Group is marked with the resumption of listing on the Shanghai Stock Exchange on March 9 this year，Completed with Shanghai Industrial Group、Reorganization of the core pharmaceutical assets under the Shanghai Pharmaceutical Group。New medicine is committed to becoming the entire industry chain covering the pharmaceutical industry、The most competitive comprehensive pharmaceutical industry group and the main integrated person in the Chinese pharmaceutical industry，Layout the Shandong market is the first step that it takes。"We will integrate other resources in Shandong in 3 years，Enter the forefront of the Shandong Pharmaceutical Distribution Market。"Ge Jianqiu, Vice President of Shanghai Pharmaceutical stake betting appstake online sports bettingGroup Co., Ltd. said，Next new medicine will also copy and promote this cooperation mode in Shandong，Accelerate the pace of expansion nationwide。
It is understood，Shanghai Pharmaceutical Distribution Holdings Co., Ltd.，It is also China's largest current scale、One of the most widely network medical business enterprises，Founded in 1997 Shandong Commercial Lianhua Biochemical Pharmaceutical Co., Ltd.，has gradually formed Jinan as the center、The pharmaceutical marketing network covering Shandong，cooperation between the two can be described as complementary advantages。According to disclosure，New Company Shanghai Fang Fang accounts for 60%of the shares，Shandong Shanglian Biochemical accounts for 40%of the shares。
